Citations

Mayo Clinic

Showing 10 of 108602 citations.

Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects
Faggionato, Edoardo , LAURENTI, MARCELLO C. , Man, Chiara Dalla , Dalla Man, Chiara , Vella, Adrian

IEEE Transactions on Biomedical Engineering | March 29, 2023 | Volume: 70 | Issue: 9 | Pages: 2733-2740

10.1109/tbme.2023.3262974 | PMID 37030857 Get It

Paper 24: Osteochondritis Dissecans of the Capitellum of the Elbow: A Comparison of Non-Operative and Surgical Outcomes at Long-Term Follow-up
Braig, Zachary, Uvodich, Mason E. , Till, Sara E., Reinholz, Anna K., Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , O’Driscoll, Shawn W. , Camp, Christopher L.

Orthopaedic Journal of Sports Medicine | March 29, 2023 | Volume: 11 | Issue: 3_suppl2 | Pages: No page available

10.1177/2325967123s00024 Get It

Objectives: Osteochondritis dissecans (OCD) of the humeral capitellum is an often painful condition that typically affects the adolescent athlete. There is little consensus on treatment and a scarcity of long-term outcomes data. The purpose of this study was to (1) report the long-term outcomes associated with both operative and non-operative management of capitellar OCD, (2) identify factors associated with failure of non-operative management, and (3) determine whether delay in surgery affects final outcomes. Methods: All patients diagnosed with OCD of the capitellum from 1995-2020 within a defined geographic cohort were included. Medical records, imaging studies, and operative reports were manually reviewed to record demographic data, treatment strategies, and outcomes. Surgical treatment was considered delayed if it occurred more than 6 months after symptom onset. Results: A total of 50 elbows with a mean follow-up of 9.4 years were included. Of these, 7 (14%) were treated non-operatively and never underwent surgery during follow-up, while 43 (86%) underwent surgical intervention: 27 had early surgery and 16 underwent delayed surgery after ≥ 6 months of non-operative treatment. When compared to non-operative management, surgical management resulted in superior MEPI scores (90 vs 83, p=0.05), decreased persistence of mechanical symptoms (9% vs 50%, p<0.01), and better elbow flexion (141° vs 131°, p=0.01) at long-term follow up. Older patients had a trend toward increased failure of non-operative management (p=0.06). The presence of an intra-articular loose body strongly predicted failure of non-operative management (p=0.01; OR 13). Plain radiography and MRI had poor sensitivities for identifying loose bodies (27% and 40%, respectively). Differences in outcomes following early versus delayed surgical management were not demonstrated. Conclusions: Patients with capitellar OCD initially treated nonoperatively failed nonoperative management 70% of the time. Elbows that did not undergo surgery had slightly increased symptoms and decreased functional outcomes compared to those treated surgically. In this cohort, the greatest predictors for failure of non-operative treatment were older age and presence of a loose body; however, an initial trial of non-operative treatment did not adversely impact the success of future surgery at long term follow-up. [Table: see text][Table: see text][Table: see text][Table: see text]
Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma
Upshaw, Jenica , Nelson, Jason, Rodday, Angie Mae , Kumar, Anita J. , Klein, Andreas K. , Konstam, Marvin A. , Ky, Bonnie , Friedberg, Jonathan W. , Kent, David M. , Parsons, Susan K. , Ky, Bonnie , K Parsons, Susan , Kent, David M , Wong, John B. , Jaffe, Iris Zamir , Maurer, Matthew J.

JAMA Cardiology | March 29, 2023 | Volume: 8 | Issue: 5 | Pages: 453

10.1001/jamacardio.2023.0303 | PMID 36988926 Get It

ImportanceAnthracycline-containing regimens are highly effective for diffuse large B-cell lymphoma (DLBCL); however, patients with preexisting heart failure (HF) may be less likely to receive anthracyclines and may be at higher risk of lymphoma mortality.ObjectiveTo assess the prevalence of preexisting HF in older patients with DLBCL and its association with treatment patterns and outcomes.Design, Setting, and ParticipantsThis longitudinal cohort study used data from the Surveillance, Epidemiology, and End Results (SEER)–Medicare registry from 1999 to 2016. The SEER registry is a system of population-based cancer registries, capturing more than 25% of the US population. Linkage to Medicare offers additional information from billing claims. This study included individuals 65 years and older with newly diagnosed DLBCL from 2000 to 2015 with Medicare Part A or B continuously in the year prior to lymphoma diagnosis. Data were analyzed from September 2020 to December 2022.ExposuresPreexisting HF in the year prior to DLBCL diagnosis ascertained from billing codes required one of the following: (1) 1 primary inpatient discharge diagnosis, (2) 2 outpatient diagnoses, (3) 3 secondary inpatient discharge diagnoses, (4) 3 emergency department diagnoses, or (5) 2 secondary inpatient discharge diagnoses plus 1 outpatient diagnosis.Main Outcomes and MeasuresThe primary outcome was anthracycline-based treatment. The secondary outcomes were (1) cardioprotective medications and (2) cause-specific mortality. The associations between preexisting HF and cancer treatment were estimated using multivariable logistic regression. The associations between preexisting HF and cause-specific mortality were evaluated using cause-specific Cox proportional hazards models with adjustment for comorbidities and cancer treatment.ResultsOf 30 728 included patients with DLBCL, 15 474 (50.4%) were female, and the mean (SD) age was 77.8 (7.2) years. Preexisting HF at lymphoma diagnosis was present in 4266 patients (13.9%). Patients with preexisting HF were less likely to be treated with an anthracycline (odds ratio, 0.55; 95% CI, 0.49-0.61). Among patients with preexisting HF who received an anthracycline, dexrazoxane or liposomal doxorubicin were used in 78 of 1119 patients (7.0%). One-year lymphoma mortality was 41.8% (95% CI, 40.5-43.2) with preexisting HF and 29.6% (95% CI, 29.0%-30.1%) without preexisting HF. Preexisting HF was associated with higher lymphoma mortality in models adjusting for baseline and time-varying treatment factors (hazard ratio, 1.24; 95% CI, 1.18-1.31).Conclusions and RelevanceIn this study, preexisting HF in patients with newly diagnosed DLBCL was common and was associated with lower use of anthracyclines and lower use of any chemotherapy. Trials are needed for this high-risk population.
Hear Me Out: Mitigating Cisplatin-Induced Ototoxicity
Desai, Aakash , Das, Devika , Desai, Aakash P

JCO Oncology Practice | March 29, 2023 | Volume: 19 | Issue: 5 | Pages: 284-285

10.1200/op.23.00120 | PMID 36989461 Get It

Retrospective Evaluation of the Association of Oxacillin MIC on Acute Treatment Outcomes with Cefazolin and Antistaphylococcal Penicillins in Methicillin-Susceptible Staphylococcus aureus Bacteremia
Hess, Kyle A., Kooda, Kirstin , Shulha, Jennifer A., Mara, Kristin C. , Mara, Kristin, Go, John R, Mara, Kristin C , Shulha, Jenny , Go, John Raymond , Fida, Madiha , DeSimone, Daniel C. , Stevens, Ryan W.

Journal of Clinical Microbiology | March 29, 2023 | Volume: 61 | Issue: 4 | Pages: No page available

10.1128/jcm.00039-23 | PMID 36988505 Get It

Antistaphylococcal penicillins (ASP) and cefazolin are first-line treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. Borderline oxacillin resistance (i.e., oxacillin MICs 1-8 μg/mL) is observed in strains hyperproducing beta-lactamases.
A pilot evaluation of social needs among gynecologic oncology patients in inpatient versus outpatient settings
Nora, Anne, Hartman, Caroline, Summers, Karen M. , Syrop, Craig H., Haugsdal, Michael L , Greenwood, Anna

Proceedings in Obstetrics and Gynecology | March 29, 2023 | Volume: 12 | Issue: 1 | Pages: No page available

10.17077/2154-4751.31886 Get It

The WHO defines social determinants of health (SDoH) as the conditions in which we are born, grow, work, and live as well as other large systems that positively or negatively affect our health. Many healthcare systems currently lack the resources and strategies required to accurately assess and address SDoH. Action must be taken because studies have found that chronic diseases, including cancer, are affected by SDoH. The aim of this study is to identify the incidence of social needs in an inpatient gynecologic oncology population and its relation to patient demographics and clinical diagnostic data to guide and inform future intervention. Patients agreeing to participate in the study completed a needs assessment survey during their inpatient stay at the hospital between November 2020 to March 2021. The survey contained seven questions, six of which were questions screening for social needs including food and housing security, transportation means, financial stability, health literacy, and social support. Responses were considered positive if any degree of need was reported. Demographic and cancer diagnosis data were then collected and included zip code, race, cancer stage and age at diagnosis, treatment history, and number of hospital admissions and length of stay over the past 12 months. The most substantial reported needs across all gynecologic malignancies were social support (65%), health literacy (37%), and financial need (22%). Less need was reported in the categories of food (11%), housing (7%), and transportation (4%). SDoH have been studied in the outpatient gynecologic population and the needs seen in this study are similar to the needs of that population. However, there are likely different challenges and frequencies of unmet need in the different types of gynecologic cancers that may affect the stage at which their cancer is diagnosed as well as the number of hospital admissions related to their cancer care.
Fostering diagnostics of cardiovascular disease in diabetics using ABI and baPWV – correspondence
Manan, Sadia , Shaikh, Omer Ahmed , Shaikh, Omer Ahmed , Saleem, Kanza, Ullah, Irfan , Asghar, Muhammad Sohaib , Ullah, Irfan , Asghar, Muhammad S , Saleem, Kanza

Annals of Medicine & Surgery | March 29, 2023 | Volume: 85 | Issue: 4 | Pages: 1316-1316

10.1097/ms9.0000000000000370 | PMID 37113832 Get It

Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
Shaikh, Omer Ahmed , Shaikh, Omer Ahmed , Aftab, Rameel Muhammad, Baktashi, Haisum, Ullah, Irfan , Asghar, Muhammad Sohaib , Ullah, Irfan , Asghar, Muhammad S

Annals of Medicine & Surgery | March 29, 2023 | Volume: 85 | Issue: 4 | Pages: 1312-1313

10.1097/ms9.0000000000000338 | PMID 37113818 Get It

Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain management. A recent treatment guideline by the American Gastroenterology Association (AGA) suggests a modified approach to treating patients with IBS-D. Eight drug recommendations were made, and a set of instructions on when to employ which medication was devised. With the incorporation of these structured guidelines, a more tailored and focused approach to IBS management may become plausible.
Causes, Diagnostic Testing, and Treatment of Residual Symptoms in Patients With IBD With Quiescent Disease
Dunleavy, Katie A. , Cross, Raymond, Raffals, Laura E., Cross, Raymond K. , Dunleavy, Katie , Raffals, Laura E.

American Journal of Gastroenterology | March 29, 2023 | Volume: 118 | Issue: 11 | Pages: 1909-1914

10.14309/ajg.0000000000002267 | PMID 36988311 Get It

Ketamine for Treatment‐Resistant bipolar depression—A reality check!
Singh, Balwinder , Singh, Balwinder

Bipolar Disorders | March 29, 2023 | Volume: 25 | Issue: 3 | Pages: 247-248

10.1111/bdi.13324 | PMID 36978284 Get It